SCHEMBL26694878

SCHEMBL26694878

Cc1ccc(S(=O)(=O)OCCO[C@H]2CCN[C@@H]2C(=O)O)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ STAT3 P40763 2/20 0.39
▸ ALDH1A1 P00352 5/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ CYP2D6 P10635 2/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ CA1 P00915 2/20 0.35
▸ CA12 O43570 1/20 0.35
▸ CA9 Q16790 1/20 0.35
▸ CTDSP1 Q9GZU7 1/20 0.35
▸ SIRT5 Q9NXA8 1/20 0.35
▸ TSHR P16473 1/20 0.34
▸ ENPP3 O14638 2/20 0.34
▸ ENPP1 P22413 2/20 0.34
▸ ENPP2 Q13822 2/20 0.34
▸ HTR6 P50406 1/20 0.34
▸ TAS2R14 Q9NYV8 1/20 0.34
▸ POLB P06746 1/20 0.34
▸ MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27043886 0.88 STAT3 (0.37) STAT3ALDH1A1MEN1KMT2ACYP2D6
SCHEMBL26694874 0.83 HTR6 (0.36) ALDH1A1MEN1CYP2C9KMT2ACYP1A2
SCHEMBL14803666 0.79 CYP2D6 (0.46) STAT3ALDH1A1CYP2C9CYP2D6CYP1A2
SCHEMBL22633334 0.76 CYP2D6 (0.43) STAT3ALDH1A1CYP2D6CYP1A2CA1
SCHEMBL22633341 0.76 CYP2D6 (0.43) STAT3ALDH1A1KMT2ACYP2D6CYP1A2
SCHEMBL22633358 0.76 CYP2D6 (0.43) STAT3ALDH1A1CYP2D6CYP1A2CA1
SCHEMBL22633332 0.76 CYP2D6 (0.43) STAT3ALDH1A1KMT2ACYP2D6CYP1A2
SCHEMBL26694930 0.74 CYP2D6 (0.39) STAT3ALDH1A1MEN1CYP2C9KMT2A
SCHEMBL27089437 0.74 STAT3 (0.39) STAT3ALDH1A1MEN1CYP2C9KMT2A
SCHEMBL28618342 0.74 ALDH1A1 (0.43) STAT3ALDH1A1MEN1CYP2C9KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240025919-A1 AZA-TETRACYCLIC OXAZEPINE COMPOUNDS AND USES THEREOF GENENTECH, INC. 2024-01-25 — — US disclosed
WO-2023225302-A1 AZA-TETRACYCLIC OXAZEPINE COMPOUNDS AND USES THEREOF GENENTECH, INC. (US) 2023-11-23 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240025919-A1 AZA-TETRACYCLIC OXAZEPINE COMPOUNDS AND USES THEREOF AZI2, TET3, OXA1L STAT3 4110/4885ALDH1A1 1000/4885MEN1 2884/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback